Cargando…
Androgen deprivation therapy for prostate cancer: indications, contraindications and possible consequences
Androgen deprivation therapy (ADT) has been the mainstay of palliative treatment in advanced and metastatic prostate cancer for many years. It is also increasingly being used in patients with localized disease. Here we review some recent trials that are providing information on its benefits and disa...
Autores principales: | Karl, Alexander, Konety, Badrinath |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Medicine Reports Ltd
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2920692/ https://www.ncbi.nlm.nih.gov/pubmed/20948762 http://dx.doi.org/10.3410/M1-2 |
Ejemplares similares
-
An Update on the Changing Indications for Androgen Deprivation Therapy for Prostate Cancer
por: Myklak, Kristene, et al.
Publicado: (2011) -
Androgen deprivation therapy and risk of cognitive dysfunction in men with prostate cancer: is there a possible link?
por: Shim, Myungsun, et al.
Publicado: (2022) -
Contemporary Management of Prostate Cancer
por: Cotter, Katherine, et al.
Publicado: (2016) -
Androgen deprivation therapy as backbone therapy in the management of prostate cancer
por: Merseburger, Axel S, et al.
Publicado: (2016) -
Cardiovascular Risks of Androgen Deprivation Therapy for Prostate Cancer
por: Corona, Giovanni, et al.
Publicado: (2021)